Barendrecht, Netherlands

Robert Benner

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Biotempt B.v.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Benner. Retrieved from https://idiyas.com/inventor/robert-benner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Robert Benner

Introduction

Robert Benner is an accomplished inventor based in Barendrecht, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the area of gene expression modulation. His work focuses on innovative treatments for inflammation, showcasing his dedication to advancing medical science.

Latest Patents

Robert Benner holds a patent for an invention titled "Oligopeptide treatment of NF-κB mediated inflammation." This invention relates to the modulation of gene expression in a cell, specifically targeting the treatment of anthrax. The method involves providing a cell with a signaling molecule that comprises a peptide or a functional analogue thereof, thereby modulating gene expression effectively.

Career Highlights

Throughout his career, Robert has demonstrated a strong commitment to research and development in biotechnology. His innovative approach to gene control has positioned him as a notable figure in his field. He works at Biotempt B.V., where he continues to explore new avenues for medical treatments.

Collaborations

Robert collaborates with Nisar Asmed Khan, leveraging their combined expertise to further their research initiatives. Their partnership exemplifies the importance of teamwork in driving innovation.

Conclusion

Robert Benner's contributions to biotechnology, particularly through his patent on oligopeptide treatments, highlight his role as a pioneering inventor. His work not only addresses critical health issues but also sets the stage for future advancements in gene therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…